NEW YORK (GenomeWeb) – CareDx today announced that two Medicare Administrative Carrier jurisdictions have issued positive decisions on covering its AlloMap molecular diagnostic surveillance test for heart transplant patients, extending coverage to Medicare patients in 11 additional states.

Four of the 12 MAC jurisdictions now cover the test. The newly affected states are Ohio, Kentucky, Oregon, Washington, Arizona, Utah, Idaho, Montana, North Dakota, South Dakota, and Wyoming.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Microsoft co-founder Paul Allen also contributed to brain research, NPR reports.

The New York Times reports on the shifting interpretations of what some genetic variants mean over time.

MIT's Technology Review reports on Genentech's pursuit of personalized cancer vaccines.

In Cell this week: investigation of metastatic tumor evolution, more than 16,000 genetic variants introduced into the budding yeast model organism, and more.